Search

everythinglearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New compounds may help treat prostate issues without affecting androgen receptors.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

New progesterone-based compounds can block male hormones.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.